Early research (Phase 1)Not Yet RecruitingNCT07341867
What this trial is testing
Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype
Who this might be right for
Multiple MyelomaTriple Negative Breast CancerDuffy Blood Group, Chemokine Receptor Gene Mutation+1 more
Andrew Hantel, MD 90